Igor Erjavec

736 total citations
31 papers, 485 citations indexed

About

Igor Erjavec is a scholar working on Molecular Biology, Biomedical Engineering and Surgery. According to data from OpenAlex, Igor Erjavec has authored 31 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Biomedical Engineering and 8 papers in Surgery. Recurrent topics in Igor Erjavec's work include Bone Tissue Engineering Materials (9 papers), TGF-β signaling in diseases (8 papers) and Orthopaedic implants and arthroplasty (7 papers). Igor Erjavec is often cited by papers focused on Bone Tissue Engineering Materials (9 papers), TGF-β signaling in diseases (8 papers) and Orthopaedic implants and arthroplasty (7 papers). Igor Erjavec collaborates with scholars based in Croatia, United States and Austria. Igor Erjavec's co-authors include Slobodan Vukičević, Lovorka Grgurević, Jelena Brkljačić, Dražen Matičić, Tatjana Bordukalo-Nikšić, Boris Maček, Ivica Grgurević, T. Kuber Sampath, Hermann Oppermann and Dražen Vnuk and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Igor Erjavec

31 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Igor Erjavec Croatia 14 184 146 122 73 58 31 485
Nathan A. Wigner United States 13 316 1.7× 112 0.8× 174 1.4× 45 0.6× 90 1.6× 17 738
Qing Zeng United States 15 330 1.8× 74 0.5× 139 1.1× 84 1.2× 49 0.8× 22 763
Makoto Watanuki Japan 6 165 0.9× 72 0.5× 56 0.5× 158 2.2× 24 0.4× 6 463
Adeline Ng Canada 8 264 1.4× 95 0.7× 59 0.5× 27 0.4× 77 1.3× 10 554
Shigeru Soshi Japan 11 141 0.8× 102 0.7× 201 1.6× 96 1.3× 102 1.8× 22 632
Yi‐Lei Wu China 12 199 1.1× 105 0.7× 71 0.6× 16 0.2× 18 0.3× 22 503
Edward J. Puzas United States 13 231 1.3× 46 0.3× 153 1.3× 59 0.8× 63 1.1× 18 550
Beatriz Gámez Spain 11 408 2.2× 124 0.8× 76 0.6× 25 0.3× 84 1.4× 13 685
Esther Lau Canada 6 166 0.9× 67 0.5× 42 0.3× 30 0.4× 32 0.6× 7 414
Naomi Dirckx United States 9 443 2.4× 109 0.7× 67 0.5× 22 0.3× 90 1.6× 16 762

Countries citing papers authored by Igor Erjavec

Since Specialization
Citations

This map shows the geographic impact of Igor Erjavec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Erjavec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Erjavec more than expected).

Fields of papers citing papers by Igor Erjavec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Erjavec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Erjavec. The network helps show where Igor Erjavec may publish in the future.

Co-authorship network of co-authors of Igor Erjavec

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Erjavec. A scholar is included among the top collaborators of Igor Erjavec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Erjavec. Igor Erjavec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Erjavec, Igor, Sven Seiwerth, Mario Carić, et al.. (2022). A case of a large pedunculated-type osteochondroma from late medieval Ilok, eastern Croatia: Bioarchaeological, paleoradiological and histological study. Journal of Archaeological Science Reports. 45. 103574–103574. 3 indexed citations
3.
Erjavec, Igor, et al.. (2022). Long-term posterolateral spinal fusion in rabbits induced by rhBMP6 applied in autologous blood coagulum with synthetic ceramics. Scientific Reports. 12(1). 11649–11649. 9 indexed citations
4.
Grgurević, Lovorka, Igor Erjavec, Munish C. Gupta, et al.. (2020). Autologous blood coagulum containing rhBMP6 induces new bone formation to promote anterior lumbar interbody fusion (ALIF) and posterolateral lumbar fusion (PLF) of spine in sheep. Bone. 138. 115448–115448. 30 indexed citations
7.
Villaseñor, Alma, David Obeso, Igor Erjavec, et al.. (2019). Metabolomics reveals citric acid secretion in mechanically–stimulated osteocytes is inhibited by high glucose. Scientific Reports. 9(1). 2295–2295. 24 indexed citations
8.
Grgurević, Lovorka, Hermann Oppermann, Igor Erjavec, et al.. (2018). Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits. JBMR Plus. 3(5). e10085–e10085. 34 indexed citations
9.
Erjavec, Igor, et al.. (2016). Mushroom Extracts Decrease Bone Resorption and Improve Bone Formation. International journal of medicinal mushrooms. 18(7). 559–569. 13 indexed citations
10.
Erjavec, Igor, Tatjana Bordukalo-Nikšić, Jelena Brkljačić, et al.. (2016). Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats. PLoS ONE. 11(2). e0150102–e0150102. 29 indexed citations
11.
Erjavec, Igor, et al.. (2016). Urodilatin reverses the detrimental influence of bradykinin in acute ischemic stroke. Experimental Neurology. 284(Pt A). 1–10. 9 indexed citations
12.
Erjavec, Igor, Tatjana Bordukalo-Nikšić, Lovorka Grgurević, Lipa Čičin‐Šain, & Slobodan Vukičević. (2016). Constitutively elevated blood serotonin is associated with bone loss and type 2 diabetes in rats. Bone Abstracts. 7 indexed citations
13.
Jurišić, Darko, Igor Erjavec, Vladimir Trkulja, et al.. (2015). Soluble type III TGFβ receptor in diagnosis and follow-up of patients with breast cancer.. PubMed. 33(3). 200–9. 10 indexed citations
14.
Dumić-Čule, Ivo, et al.. (2014). Dynamics of optic canal and orbital cavity development revealed by microCT. Surgical and Radiologic Anatomy. 36(10). 989–992. 5 indexed citations
15.
Brkljačić, Jelena, et al.. (2013). Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity. International Orthopaedics. 37(3). 529–541. 24 indexed citations
16.
Bohaček, Ivan, et al.. (2013). Computed microtomography visualization and quantification of mouse ischemic brain lesion by nonionic radio contrast agents. Croatian Medical Journal. 54(1). 3–11. 16 indexed citations
17.
Grgurević, Lovorka, Boris Maček, David R. Healy, et al.. (2011). Circulating Bone Morphogenetic Protein 1–3 Isoform Increases Renal Fibrosis. Journal of the American Society of Nephrology. 22(4). 681–692. 48 indexed citations
18.
Grgurević, Lovorka, Boris Maček, Mladen Merćep, et al.. (2011). Bone morphogenetic protein (BMP)1-3 enhances bone repair. Biochemical and Biophysical Research Communications. 408(1). 25–31. 57 indexed citations
19.
Grgurević, Lovorka, et al.. (2008). Novel biomarkers in the plasma of patients with a bone fracture. Calcified Tissue International. 82. 3 indexed citations
20.
Maček, Boris, et al.. (2007). Urine release of systemically administered bone morphogenetic protein hybrid molecule. Journal of Nephrology. 20(3). 311–319. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026